Healthy Volunteers Clinical Trial
Official title:
Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions
Objective:
The goal of this protocol is to improve understanding scale-free brain activity and conscious
vs. unconscious processing by performing small behavioral, electrophysiological, neuroimaging
and brain stimulation pilot substudies. This research is expected to help develop techniques
and hypotheses for future research on these topics.
We will conduct:
- Pilot Substudy: Pilot substudies are exploratory in nature, in order to develop enough
information to generate a hypothesis. The criterion for transition to a new full
protocol will be acquisition of sufficient information to generate a power analysis.
There are no enrollment limitations for pilot substudies.
- Hypothesis-Testing Substudy is defined as a study with a specific hypothesis to be
tested that can be completed with a few healthy volunteers or patients.
Hypothesis-testing substudies will undergo statistical and PIRC reviews after 6 subjects
(if there is one group) or after 12 (6 per arm) if two groups are studied before
additional subjects are recruited. In the event of subject dropout or unsuccessful
recording, replacement will be recruited. Together, the P.I. and PIRC will decide
whether to continue the hypothesis substudy with more subjects without an amendment or
whether an amendment or new protocol would be necessary. A memo requesting a review of
hypothesis-testing substudies for possible additional enrollment will be sent to PIRC
and the statistical reviewer. The memo will be forwarded to the CNS IRB.
- Technical development of new experimental paradigms and data analysis methods.
This protocol includes only non-invasive techniques with minimal risk (MRI, EEG, MEG, EMG,
tDCS).
Study Population:
We plan to recruit up to 120 healthy volunteers aged 18-65.
Design:
We will design small projects that are pertinent to the theme of scale-free brain activity
and conscious/unconscious processing. We will investigate healthy volunteers in the resting
state or while they perform simple motor or sensory tasks. If a hypothesis testing substudy
leads to results of interest and if a larger population is necessary to reach statistical
significance, a separate protocol will be submitted with a priori hypotheses, specific study
design and power analysis adapted from the pilot or exploratory substudies performed in the
present protocol.
In the substudies, brain activity of healthy human volunteers will be monitored by functional
magnetic resonance imaging (fMRI), magnetoencephalography (MEG), electroencephalography
(EEG), or simultaneous MEG-EEG. Anatomical MRI will be collected in some subjects to allow
better localization of brain dynamics. Because transcranial direct-current stimulation (tDCS)
is ideally suited to modulate the slow component of scale-free brain activity, we will also
investigate the effect of tDCS on brain activity and/or behavioral performance in cognitive
tasks. tDCS will be administered sequentially, but not simultaneously, with brain-activity
monitoring by fMRI/MEG/EEG. Most experiments will be conducted in conjunction with cognitive
tasks. In some experiments, we will study resting-state brain function, during which
spontaneous brain activity is collected without a specific externally administered task.
Outcome Measures:
MRI: to analyze measures such as the anatomical structures of the brain (using structural
MRI); amplitude of the blood-oxygenation-level-dependent (BOLD) signal (using fMRI); cerebral
blood flow [using arterial spin labeling (ASL)] and different neurotransmitter levels in
brain regions of interest [using magnetic resonance spectroscopy (MRS)].
EEG and MEG: to quantify measures such as power spectrum, event- or task-related potentials,
synchronization/desynchronization, and coherence between sensors or sources located close to
the brain areas of interest.
tDCS: to analyze changes in behavioral measures and/or fMRI/EEG/MEG activity caused by tDCS.
Behavioral measures: to quantify measures such as hit rate, reaction times, electromyography
(EMG) patterns.
We may measure autonomic data during the course of the experiment (such as heart rate,
respiration, end-tidal CO2, skin conductance), which will be correlated with the outcome
measures.
Objective:
The goal of this protocol is to improve understanding scale-free brain activity and conscious
vs. unconscious processing by performing small behavioral, electrophysiological, neuroimaging
and brain stimulation pilot substudies. This research is expected to help develop techniques
and hypotheses for future research on these topics.
We will conduct:
- Pilot Substudy: Pilot substudies are exploratory in nature, in order to develop enough
information to generate a hypothesis. The criterion for transition to a new full
protocol will be acquisition of sufficient information to generate a power analysis.
There are no enrollment limitations for pilot substudies.
- Hypothesis-Testing Substudy is defined as a study with a specific hypothesis to be
tested that can be completed with a few healthy volunteers or patients.
Hypothesis-testing substudies will undergo statistical and PIRC reviews after 6 subjects
(if there is one group) or after 12 (6 per arm) if two groups are studied before
additional subjects are recruited. In the event of subject dropout or unsuccessful
recording, replacement will be recruited. Together, the P.I. and PIRC will decide
whether to continue the hypothesis substudy with more subjects without an amendment or
whether an amendment or new protocol would be necessary. A memo requesting a review of
hypothesis-testing substudies for possible additional enrollment will be sent to PIRC
and the statistical reviewer. The memo will be forwarded to the CNS IRB.
- Technical development of new experimental paradigms and data analysis methods.
This protocol includes only non-invasive techniques with minimal risk (MRI, EEG, MEG, EMG,
tDCS).
Study Population:
We plan to recruit up to 200 healthy volunteers aged 18-65.
Design:
We will design small projects that are pertinent to the theme of scale-free brain activity
and conscious/unconscious processing. We will investigate healthy volunteers in the resting
state or while they perform simple motor or sensory tasks. If a hypothesis testing substudy
leads to results of interest and if a larger population is necessary to reach statistical
significance, a separate protocol will be submitted with a priori hypotheses, specific study
design and power analysis adapted from the pilot or exploratory substudies performed in the
present protocol.
In the substudies, brain activity of healthy human volunteers will be monitored by functional
magnetic resonance imaging (fMRI), magnetoencephalography (MEG), electroencephalography
(EEG), or simultaneous MEG-EEG. Anatomical MRI will be collected in some subjects to allow
better localization of brain dynamics. Because transcranial direct-current stimulation (tDCS)
is ideally suited to modulate the slow component of scale-free brain activity, we will also
investigate the effect of tDCS on brain activity and/or behavioral performance in cognitive
tasks. tDCS will be administered sequentially, but not simultaneously, with brain-activity
monitoring by fMRI/MEG/EEG. Most experiments will be conducted in conjunction with cognitive
tasks. In some experiments, we will study resting-state brain function, during which
spontaneous brain activity is collected without a specific externally administered task.
Outcome Measures:
MRI: to analyze measures such as the anatomical structures of the brain (using structural
MRI); amplitude of the blood-oxygenation-level-dependent (BOLD) signal (using fMRI); cerebral
blood flow [using arterial spin labeling (ASL)] and different neurotransmitter levels in
brain regions of interest [using magnetic resonance spectroscopy (MRS)].
EEG and MEG: to quantify measures such as power spectrum, event- or task-related potentials,
synchronization/desynchronization, and coherence between sensors or sources located close to
the brain areas of interest.
tDCS: to analyze changes in behavioral measures and/or fMRI/EEG/MEG activity caused by tDCS.
Behavioral measures: to quantify measures such as hit rate, reaction times, electromyography
(EMG) patterns.
We may measure autonomic data during the course of the experiment (such as heart rate,
respiration, end-tidal CO2, skin conductance), which will be correlated with the outcome
measures.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |